MediPharm Labs Corp. (LABS.TO) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MediPharm Labs Corp. (LABS.TO) in the last twelve months. There are currently 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MediPharm Labs Corp. (LABS.TO) stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in LABS, but not buy additional shares or sell existing shares.
View analyst ratings for MediPharm Labs Corp. (LABS.TO) or view top-rated stocks.

Wall Street analysts have given MediPharm Labs Corp. (LABS.TO) a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MediPharm Labs Corp. (LABS.TO) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

MediPharm Labs Corp. (LABS.TO) is scheduled to release its next quarterly earnings announcement on Thursday, March 25th 2021.
View our earnings forecast for MediPharm Labs Corp. (LABS.TO).

MediPharm Labs Corp. (LABS.TO)'s stock was trading at C$1.84 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, LABS stock has decreased by 73.6% and is now trading at C$0.49.
View which stocks have been most impacted by COVID-19.

4 brokers have issued 12 month price objectives for MediPharm Labs Corp. (LABS.TO)'s stock. Their forecasts range from C$1.25 to C$2.50. On average, they expect MediPharm Labs Corp. (LABS.TO)'s share price to reach C$1.98 in the next year. This suggests a possible upside of 308.2% from the stock's current price.
View analysts' price targets for MediPharm Labs Corp. (LABS.TO) or view top-rated stocks among Wall Street analysts.

Some companies that are related to MediPharm Labs Corp. (LABS.TO) include Willow Biosciences Inc. (WLLW.TO) (WLLW), Qilian International Holding Group (QLI), XPhyto Therapeutics (XPHYF), CAVU Resources (CAVR), Khiron Life Sciences Corp. (KHRN.V) (KHRN), Delta 9 Cannabis (DN), Jupiter Wellness (JUPW), Meta Growth Corp. (META.V) (META), 48North Cannabis Corp. (NRTH.V) (NRTH), FSD Pharma (HUGE), (CSI) (CSI), (IMCC) (IMCC), 1933 Industries (TGIFF), 28896 (BAMM) and 4Front Ventures (FFNTF).
View all of LABS's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other MediPharm Labs Corp. (LABS.TO) investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Village Farms International, Inc. (VFF.TO) (VFF), Canopy Growth (WEED), Aphria (APHA), Cresco Labs (CRLBF), HEXO Corp. (HEXO.TO) (HEXO), Heat Biologics (HTBX), Absolute Software Co. (ABT.TO) (ABT) and Acasti Pharma (ACST).

MediPharm Labs Corp. (LABS.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "LABS."

Shares of LABS and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

One share of LABS stock can currently be purchased for approximately C$0.49.

MediPharm Labs Corp. (LABS.TO) has a market capitalization of C$67.70 million and generates C$62.40 million in revenue each year.

MediPharm Labs Corp. (LABS.TO) employs 230 workers across the globe.

The official website for MediPharm Labs Corp. (LABS.TO) is www.medipharmlabs.com.

The company can be reached via phone at 705 719 7425.